2014-06-26 12:57:19 UTC

Your GI Research May Create the Next New Drug

July 3, 2014

Apply by July 28 to be considered to work directly with an international pharmaceutical company and bring your research to life.

Are you interested in working with a commercial partner to bring your GI research to life?

Funded by Takeda Pharmaceuticals International, Inc. and the AGA Research Foundation, researchers are invited to submit a summary of their concept for collaboration that could yield a new drug or molecular diagnostic relevant to celiac disease or GI motility disorder (particularly those involving neural/ hormonal dysfunction or the gut microbiome). The deadline to submit an application is July 28, 2014.

The most promising will be invited to present their concepts in person at a private conference held at Takeda Pharmaceuticals International, Inc. headquarters near Chicago on Oct. 8, 2014, and may be chosen to work directly with this international company to further develop their promising ideas.

View additional details and apply at www.gastro.org/discovery.

More on Celiac Disease

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

Attend the AGA Postgraduate Course for Practical, Take Home Information

Feb. 12, 2018

Join us on June 2-3 in Washington, D.C. This course is held in conjunction with Digestive Disease Week® (DDW) 2018.

Digestive Disease Week® (DDW)

Dec. 19, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.